Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 10613-ER

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
10613-ER-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

CHO

Accession #

XP_005584091.2

Conjugate

Unconjugated

Applications

Bioactivity

View all ErbB2/Her2 Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived cynomolgus monkey ErbB2/Her2 protein
Thr23-Thr652, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Thr23

Predicted Molecular Mass

70 kDa

SDS-PAGE

95-110 kDa, under reducing conditions

Activity

Measured by its ability to block anti-ErbB2 mediated inhibition of SK-BR-3 human breast cancer cell proliferation. Brodowicz, T. et al. (1997) Int. J. Cancer 73:875.
The ED50 for this effect is 0.7-7 μg/mL in the presence of 0.6 µg/mL Human ErbB2/Her2 Antibody (Trastuzumab, Catalog # MAB9589).

Scientific Data Images for Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag Protein, CF

Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag Protein Bioactivity.

Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag Protein (Catalog # 10613-ER) blocks anti-ErbB2 mediated inhibition of the SK-BR-3 human breast cancer cell line proliferation. The ED50 is 0.7-7 μg/mL in the presence of 0.6 μg/mL Trastuzumab (Human ErbB2/Her2 Antibody, MAB9589).

Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag Protein SDS-PAGE

2 μg/lane of Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag (Catalog # 10613-ER) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 95-110 kDa.

Formulation, Preparation and Storage

10613-ER
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 500 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: ErbB2/Her2

ErbB2, also called human epidermal growth factor receptor 2 (HER2) and Neu, is a type I membrane glycoprotein and is one of four members of the ErbB family of receptor tyrosine kinases. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of growth factors. Cynomolgus ErbB2 consists of an extracellular domain (ECD) with two ligand binding domains and two cystine rich domains, a transmembranee region and a cytoplasmic domain with a flexible juxtamembrane region followed by a protein kinase domain (1). The ECD of mature cynomolgus ErbB2 shares 99% amino acid sequence identity with the ECD of human ErbB2. ErbB2 signaling is associated with neurodegenerative diseases such as multiple sclerosis and Alzheimer disease when impaired, while over-expression of ErbB2 signaling is associated with development of cancers (2). ErbB2 is widely expressed in epithelial cells and has been primarily associated with breast carcinomas (3, 4). Over-expression of HER-2 also caused other cancers such as gastric (2,5), colorectal (6), ovary, lung, bladder, head and neck (7), and osteosarcoma (8). Among ErbB family members, ErbB2 is unique in that it has no identified ligands. Rather, ErbB2 heterodimerizes with the other members of the ErbB family to form higher affinity signaling complexes (9). ErbB2 can be shed from the cell surface by the protease ADAM10, resulting in a constitutively active truncated intracellular receptor (10). ERBB2 is used as biomarkers in several cancers and is an attractive oncogenic driver and therapeutic target in cancers (6).

References

  1. Ferguson, K.M. (2008) Annu Rev Biophys. 37:353.
  2. Boku, N. (2014) Gastric Cancer. 17:1.
  3. Harari, D. and Yarden, Y. (2000) Oncogene 19:6102.
  4. Bertucci, F. et al. (2004) Oncogene 23:2564
  5. Palle J. et al. (2020) Drug 80(4):401.
  6. De Cuyper, A. et al. (2020) Clin Colorectal Cancer. 19(2):65.
  7. Vats, S. et al. (2018) Indian Journal Pathology & Microbiology.
  8. Hughes, D.P. et al. (2004) Cancer Res 64(6):2047.
  9. Citri, A. et al. (2003) Exp Cell Res. 284:54.
  10. Liu, P.C. et al. (2006) Cancer Biol Ther. 5:657.

Long Name

Receptor Tyrosine Protein Kinase ErbB2

Alternate Names

CD340, HER2, Neu Oncogene, NGL, TKR1

Entrez Gene IDs

2064 (Human); 13866 (Mouse); 24337 (Rat); 102146608 (Cynomolgus Monkey)

Gene Symbol

ERBB2

UniProt

XP_005584091.2

Additional ErbB2/Her2 Products

Product Documents for Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Cynomolgus Monkey ErbB2/Her2 His-tag Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.